2021 News
-
IR News
-
IR News
-
Information
Santen and Ube Industries receives Complete Response Letter from FDA for STN1011700/DE-117
-
IR News
Santen to Present Latest Data on Omidenepag Isopropyl at AAO 2021
-
IR News
Santen Reports the 2nd Quarter Fiscal 2021 Consolidated Performance
-
IR News
-
IR News
Santen to Present Latest Data on STN2000100 (DE-128, MicroShunt) at 39th ESCRS
-
IR News
-
IR News
-
IR News
-
IR News
-
IR News
Santen to Present Latest Data including STN1012700 (DE-127) at APAO 2021
-
IR News
-
IR News
Notice on the Selection to Apply to New Market Segment 'Prime Market' on the Tokyo Stock Exchange
-
IR News
-
IR News
-
IR News
-
IR News
Santen Reports the 1st Quarter Fiscal 2021 Consolidated Performance
-
IR News
-
IR News
-
IR News
Santen to Present Latest Data on STN2000100 at 2021 ASCRS Annual Meeting
-
IR News
-
IR News
Santen's CO2 emission reduction targets endorsed by the Science Based Targets (SBT) initiative
-
IR News
Notice on the Disposal of Treasury Shares Under Restricted Stock-Linked Remuneration Program
-
IR News
-
IR News
Santen to Present Latest Data on STN2000100 at COS 2021 and 9th WGC
-
IR News
Santen to Present Latest Data on Omidenepag Isopropyl at APGC 2021
-
IR News
-
IR News
-
IR News
-
IR News
-
IR News
Notice of Board of Director and Corporate Auditor Nominations
-
IR News
-
IR News
-
IR News
-
IR News
Notice of Recording of Impairment Loss and Revision of Full-Year Earnings Forecasts
-
IR News
-
IR News
Santen Announces Sponsorship of IBSA Blind Football World Grand Prix for the Second Consecutive Year
-
IR News
-
IR News
Santen Reports the 3rd Quarter Fiscal 2020 Consolidated Performance
-
IR News
-
IR News
-
IR News
Santen to Hold a Presentation for the 39th Annual J.P. Morgan Healthcare Conference
-
IR News